Get certified in ACLS Recertification for just $175.00.
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
Procainamide is effective in slowing the conduction in the atria, the ventricles and the Bundle of HIS Purkinje system. It does this by prolonging the P to R and the Q to T intervals and slows the refractory periods of the atria and ventricles as well as the refractory period of the atrioventricular node. Procainamide has been effective for the treatment of supraventricular tachycardia that returns after vagal maneuvers and adenosine were ineffective. It helps treat stable wide complex tachycardia of uncertain origin, stable monomorphic ventricular tachycardia with normal QT interval, atrial fibrillation with a rapid ventricular rate response in patients with Wolff-Parkinson-White syndrome and recurrent ventricular fibrillation or pulseless v-tach. There are some contraindications with the use of procainamide. It’s important to be aware of any known sensitivity to procainamide or similar medications. Digitalis toxicity may complicate already existing AV conduction depression. Other contraindications would include third degree heart block or preexisting prolongation of the QRS complex and Q-T intervals. Procainamide should be avoided in patients with prolonged Q-T intervals and associated CHF. Alright, so now let’s talk about the adult dosage for procainamide. Remember that the use of procainamide is limited in ACLS for cardiac arrest due to its requirements of slow infusion and its sometimes unknown effectiveness. If it is used for recurrent ventricular fibrillation and pulseless ventricular tachycardia, we’re going to want to give 20 mg per minute IV infusion to a total dose of 17 mg per kg. For supraventricular tachycardia, atrial fibrillation and wide complex tachycardias of uncertain origin administer procainamide at 20 mg per minute via IV infusion to that total of 17 mg per kg. For maintenance, it can be administered at 1 to 4 mg per min titrated to desired effect and the patient’s response. Please note, the use of procainamide should be stopped if any of the following occurs, arrhythmia suppression, onset of hypotension, QRS complex widens by greater than 50% of the pretreatment width or the maximum dose of 17 mg per kg is reached.
In this lesson, we'll go over the medication procainamide and all of its effects, including indications, precautions and contraindications, and adult dosages. And at the end of the lesson, we provide you with a Word about wide complex tachycardias.
Procainamide is effective at slowing the conduction in the atria, ventricles, and the His-Purkinje system by prolonging the P-R and Q-T intervals and the refractory period of the AV node. Procainamide also slows the refractory period within the atria and ventricles and slows the conduction velocity.
Now let's take a look at procainamide indications.
Procainamide is effective for the treatment of supraventricular tachycardia that returns after vagal maneuvers and adenosine are ineffective.
Procainamide is also effective at treating the following:
Warning: it's important that you're aware of any known patient sensitivity to procainamide or similar medications before administering it.
Also important to note is that digitalis toxicity may complicate an already existing AV conduction depression. Other procainamide contraindications would include:
Pro Tip #1: The use of procainamide should be avoided in patients with prolonged QT intervals and associated congestive heart failure (CHF).
Now let's look at the adult dosage for procainamide.
Pro Tip #2: The use of procainamide is limited in ACLS for cardiac arrest due to its requirements of slow infusion, as well as its occasional unknown effectiveness.
If you're administering procainamide for recurrent ventricular fibrillation and pulseless V-tach, you should give 20mg per minute via IV infusion up to total max dose of 17mg per kg.
For supraventricular tachycardia, atrial fibrillation, and wide complex tachycardia of uncertain origin, administer procainamide at 20mg per minute via IV infusion up to a total maximum dose of 17mg per kg.
For maintenance doses of procainamide, administer the drug at 1 to 4mg per minute titrated to the desired effect and the patient response.
It's important to note that the use of procainamide should be stopped if any of the following occurs:
Since wide complex tachycardias are one instance in which you may administer procainamide, let's take a broader look at it.
Wide-complex tachycardias are defined as a QRS of 0.12 seconds or more. The most common types of life threatening wide complex tachycardias that are likely to deteriorate to ventricular fibrillation are:
You should determine if the rhythm is regular or irregular:
These are all advanced rhythms requiring expert consultation.
If the rhythm is likely ventricular tachycardia or supraventricular tachycardia in a stable patient, treat the condition based on the algorithm for that rhythm. If the rhythm etiology cannot be determined and is regular in its rate and monomorphic, recent research and evidence suggests that adenosine administered via IV is relatively safe for both treatment and diagnosis.
IV antiarrhythmic drugs may be effective. The American Heart Association recommends procainamide, amiodarone, or sotalol.
In the case of irregular wide-complex tachycardia, management of the condition should be focused on controlling the rapid ventricular rate, the conversion of hemodynamically unstable atrial fibrillation to sinus rhythm, or both. Again, expert consultation is advised.